<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8473495" created="02/11/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8473495</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="negative_transcriptional_regulation" sem="Other">Negative transcriptional regulation</term> of <term id="T2" lex="human_interleukin_2_(IL-2)_gene" sem="DNA_domain_or_region"><term id="T3" lex="human_interleukin_2" sem="Protein_molecule">human interleukin 2</term> (<term id="T4" lex="IL-2" sem="Protein_molecule">IL-2</term>) gene</term> by <term id="T5" lex="glucocorticoid" sem="Lipid">glucocorticoids</term> through interference with <term id="T6" lex="nuclear_transcription_factor" sem="Protein_family_or_group">nuclear transcription factors</term> <term id="T7" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T8" lex="NF-AT" sem="Protein_molecule">NF-AT</term>.</sentence>
<event KT="Other" id="E1">
<type class="Negative_regulation"/>
<theme idref="T7"/>
<cause idref="T5"/>
<clue>Negative transcriptional <clueType>regulation</clueType> of human interleukin 2 (IL-2) gene <linkCause>by</linkCause> glucocorticoids <clueType>through interference</clueType> <linkTheme>with</linkTheme> nuclear transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E2">
<type class="Negative_regulation"/>
<theme idref="T8"/>
<cause idref="T5"/>
<clue>Negative transcriptional <clueType>regulation</clueType> of human interleukin 2 (IL-2) gene <linkCause>by</linkCause> glucocorticoids <clueType>through interference</clueType> <linkTheme>with</linkTheme> nuclear transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Negative_regulation"/>
<theme idref="T2"/>
<cause idref="E1"/>
<clue><clueType>Negative transcriptional regulation</clueType> <linkTheme>of</linkTheme> human interleukin 2 (IL-2) gene by glucocorticoids <linkCause>through</linkCause> interference with nuclear transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Negative_regulation"/>
<theme idref="T2"/>
<cause idref="E2"/>
<clue><clueType>Negative transcriptional regulation</clueType> <linkTheme>of</linkTheme> human interleukin 2 (IL-2) gene by glucocorticoids <linkCause>through</linkCause> interference with nuclear transcription factors AP-1 and NF-AT.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T9" lex="IL-2_gene_transcription" sem="Other"><term id="T10" lex="IL-2_gene" sem="DNA_domain_or_region">IL-2 gene</term> transcription</term> is affected by several <term id="T11" lex="nuclear_protein" sem="Protein_family_or_group">nuclear proteins</term>.</sentence>
<event KT="Other" id="E5">
<type class="Transcription"/>
<theme idref="T10"/>
<clue>IL-2 gene <clueType>transcription</clueType> is affected by several nuclear proteins.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="T11"/>
<clue>IL-2 gene transcription is <clueType>affected</clueType> <linkCause>by</linkCause> several nuclear proteins.</clue>
</event>
<sentence id="S3">We asked whether <term id="T12" lex="dexamethasone" sem="Lipid">dexamethasone</term> (<term id="T13" lex="Dex" sem="Lipid">Dex</term>) and <term id="T14" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term> (<term id="T15" lex="CsA" sem="Organic_compound_other">CsA</term>) inhibit <term id="T16" lex="IL-2_gene_transcription" sem="Other"><term id="T17" lex="IL-2_gene" sem="DNA_domain_or_region">IL-2 gene</term> transcription</term> by interfering with the activity of <term id="T18" lex="nuclear_protein" sem="Protein_family_or_group">nuclear proteins</term> that bind to the <term id="A1" sem="DNA_domain_or_region">IL-2 promoter</term>.</sentence>
<event KT="Other" id="E7" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T18"/>
<cause idref="T13"/>
<clue>We asked whether dexamethasone (Dex) and cyclosporin A (CsA) <clueType>inhibit</clueType> IL-2 gene transcription <clueType>by interfering</clueType> <linkTheme>with</linkTheme> the activity of nuclear proteins that bind to the IL-2 promoter.</clue>
</event>
<event KT="Other" id="E8" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T18"/>
<cause idref="T15"/>
<clue>We asked whether dexamethasone (Dex) and cyclosporin A (CsA) <clueType>inhibit</clueType> IL-2 gene transcription <clueType>by interfering</clueType> <linkTheme>with</linkTheme> the activity of nuclear proteins that bind to the IL-2 promoter.</clue>
</event>
<event KT="Other" id="E9">
<type class="Transcription"/>
<theme idref="T17"/>
<clue>We asked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 gene <clueType>transcription</clueType> by interfering with the activity of nuclear proteins that bind to the IL-2 promoter.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="E7"/>
<clue>We <clueKT>asked</clueKT> whether dexamethasone (Dex) and cyclosporin A (CsA) <clueType>inhibit</clueType> IL-2 gene transcription <linkCause>by</linkCause> interfering with the activity of nuclear proteins that bind to the IL-2 promoter.</clue>
</event>
<event KT="Investigation" id="E11" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="E8"/>
<clue>We <clueKT>asked</clueKT> whether dexamethasone (Dex) and cyclosporin A (CsA) <clueType>inhibit</clueType> IL-2 gene transcription <linkCause>by</linkCause> interfering with the activity of nuclear proteins that bind to the IL-2 promoter.</clue>
</event>
<event KT="Other" id="E12">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="A1"/>
<clue>We asked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 gene transcription by interfering with the activity of nuclear proteins that <clueType>bind</clueType> to the IL-2 promoter.</clue>
</event>
<sentence id="S4">Nuclear extracts from <term id="T19" lex="primary_human_T_lymphocyte" sem="Cell_natural">primary human T lymphocytes</term> were analyzed by <term id="T20" lex="electrophoretic_DNA_mobility_shift_assay" sem="Other">electrophoretic DNA mobility shift assays</term>.</sentence>
<sentence id="S5">Both <term id="T21" lex="Dex" sem="Lipid">Dex</term> and <term id="T22" lex="CsA" sem="Organic_compound_other">CsA</term> inhibited the binding of transcription factors <term id="T23" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T24" lex="NF-AT" sem="Protein_molecule">NF-AT</term>, but not of <term id="T25" lex="NF-kB" sem="Protein_family_or_group">NF-kB</term> and <term id="T26" lex="OCT-1/OAF" sem="Protein_molecule">OCT-1/OAF</term>, to <term id="A2" sem="DNA_domain_or_region">their corresponding sites on the <term id="T27" lex="IL-2_gene_promoter" sem="DNA_domain_or_region">IL-2 gene promoter</term></term>.</sentence>
<event KT="Other" id="E13">
<type class="Binding"/>
<theme idref="T23"/>
<theme idref="A2"/>
<clue>Both Dex and CsA inhibited the <clueType>binding</clueType> <linkTheme>of</linkTheme> transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, <linkTheme>to</linkTheme> their corresponding sites on the IL-2 gene promoter.</clue>
<comment>TPS A2</comment></event>
<event KT="Other" id="E14">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="A2"/>
<clue>Both Dex and CsA inhibited the <clueType>binding</clueType> <linkTheme>of</linkTheme> transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, <linkTheme>to</linkTheme> their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E15">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="A2"/>
<clue>Both Dex and CsA inhibited the <clueType>binding</clueType> of transcription factors AP-1 and NF-AT, but not <linkTheme>of</linkTheme> NF-kB and OCT-1/OAF, <linkTheme>to</linkTheme> their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E16">
<type class="Binding"/>
<theme idref="T26"/>
<theme idref="A2"/>
<clue>Both Dex and CsA inhibited the <clueType>binding</clueType> of transcription factors AP-1 and NF-AT, but not <linkTheme>of</linkTheme> NF-kB and OCT-1/OAF, <linkTheme>to</linkTheme> their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T21"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T21"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T22"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T22"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T21"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but <cluePolarity>not</cluePolarity> of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T21"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but <cluePolarity>not</cluePolarity> of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T22"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but <cluePolarity>not</cluePolarity> of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T22"/>
<clue>Both Dex and CsA <clueType>inhibited</clueType> the binding of transcription factors AP-1 and NF-AT, but <cluePolarity>not</cluePolarity> of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter.</clue>
</event>
<sentence id="S6">To correlate changes in <term id="A3" sem="Protein_family_or_group">nuclear factor</term> binding in vitro with transcriptional activity in vivo and define the structural requirements for <term id="T28" lex="IL-2_promoter_repression" sem="Other"><term id="T29" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term> repression</term>, we used transient DNA transfections.</sentence>
<event KT="Other" id="E25">
<type class="Binding"/>
<theme idref="A3"/>
<clue>To correlate changes in nuclear factor <clueType>binding</clueType> in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections.</clue>
</event>
<event KT="Other" id="E26">
<type class="Regulation"/>
<theme idref="E25"/>
<clue>To correlate <clueType>changes</clueType> in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<cause idref="A3"/>
<clue>To correlate changes in nuclear factor binding in vitro with <clueType>transcriptional activity</clueType> in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections.</clue>
</event>
<event KT="Investigation" id="E28" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E26"/>
<theme idref="E27"/>
<clue><clueKT>To</clueKT> <clueType><clueKT>correlate</clueKT></clueType> changes in nuclear factor binding in vitro <linkTheme>with</linkTheme> transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections.</clue>
</event>
<event KT="Other" id="E29">
<type class="Negative_regulation"/>
<theme idref="T29"/>
<clue>To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter <clueType>repression</clueType>, we used transient DNA transfections.</clue>
</event>
<event KT="Investigation" id="E30" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="A3"/>
<clue><clueKT>To</clueKT> correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and <clueKT>define</clueKT> the structural <clueType>requirements</clueType> <linkTheme>for</linkTheme> IL-2 promoter repression, we used transient DNA transfections.</clue>
</event>
<sentence id="S7"><term id="T30" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term> were transfected with <term id="T31" lex="plasmid" sem="DNA_molecule">plasmids</term> containing either the intact <term id="T32" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term> or its <cons id="T33" lex="(AND AP-1_motif NF-AT_motif NF-kB_motif)" sem="(AND DNA_domain_or_region DNA_domain_or_region DNA_domain_or_region)"><frag id="F1"><term id="A5" sem="Protein_complex">AP-1</term></frag>, <frag id="F2"><term id="A6" sem="Protein_family_or_group">NF-AT</term></frag>, and <frag id="F3"><term id="A7" sem="Protein_complex">NF-kB</term></frag> <frag id="F4">motifs</frag></cons>.</sentence>
<sentence id="S8"><term id="A4" sem="Lipid">Dex</term> inhibited the <term id="T34" lex="IL-2_promoter" sem="DNA_molecule">IL-2 promoter</term> and the <term id="T35" lex="AP-1_plasmid" sem="DNA_molecule">AP-1</term>, but not the <term id="T36" lex="NF-AT_plasmid" sem="DNA_molecule">NF-AT</term> and <term id="T37" lex="NF-kB_plasmid" sem="DNA_molecule">NF-kB</term> <term id="A9" sem="DNA_molecule">plasmids</term>.</sentence>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="T34" idref1="A9"/>
<cause idref="A4"/>
<clue>Dex <clueType>inhibited</clueType> the IL-2 promoter and the AP-1, but not the NF-AT and NF-kB plasmids.</clue>
<comment>NER T34,T37 MOD</comment></event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="T35" idref1="A9"/>
<cause idref="A4"/>
<clue>Dex <clueType>inhibited</clueType> the IL-2 promoter and the AP-1, but not the NF-AT and NF-kB plasmids.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E33">
<type class="Negative_regulation"/>
<theme idref="T36" idref1="A9"/>
<cause idref="A4"/>
<clue>Dex <clueType>inhibited</clueType> the IL-2 promoter and the AP-1, but <cluePolarity>not</cluePolarity> the NF-AT and NF-kB plasmids.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E34">
<type class="Negative_regulation"/>
<theme idref="T37" idref1="A9"/>
<cause idref="A4"/>
<clue>Dex <clueType>inhibited</clueType> the IL-2 promoter and the AP-1, but <cluePolarity>not</cluePolarity> the NF-AT and NF-kB plasmids.</clue>
</event>
<sentence id="S9">In contrast, <term id="T38" lex="CsA" sem="Organic_compound_other">CsA</term> inhibited the <term id="T39" lex="IL-2_promoter" sem="DNA_molecule">IL-2 promoter</term> and the <term id="T40" lex="NF-AT_plasmid" sem="DNA_molecule">NF-AT</term>, but not the <term id="T41" lex="AP-1_plasmid" sem="DNA_molecule">AP-1</term> and <term id="T42" lex="NF-kB_plasmid" sem="DNA_molecule">NF-kB</term> <term id="A10" sem="DNA_molecule">plasmids</term>.</sentence>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="T39" idref1="A10"/>
<cause idref="T38"/>
<clue>In contrast, CsA <clueType>inhibited</clueType> the IL-2 promoter and the NF-AT, but not the AP-1 and NF-kB plasmids.</clue>
<comment>NER T39,T42 MOD</comment></event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="T40" idref1="A10"/>
<cause idref="T38"/>
<clue>In contrast, CsA <clueType>inhibited</clueType> the IL-2 promoter and the NF-AT, but not the AP-1 and NF-kB plasmids.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E37">
<type class="Negative_regulation"/>
<theme idref="T41" idref1="A10"/>
<cause idref="T38"/>
<clue>In contrast, CsA <clueType>inhibited</clueType> the IL-2 promoter and the NF-AT, but <cluePolarity>not</cluePolarity> the AP-1 and NF-kB plasmids.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E38">
<type class="Negative_regulation"/>
<theme idref="T42" idref1="A10"/>
<cause idref="T38"/>
<clue>In contrast, CsA <clueType>inhibited</clueType> the IL-2 promoter and the NF-AT, but <cluePolarity>not</cluePolarity> the AP-1 and NF-kB plasmids.</clue>
</event>
<sentence id="S10">These results suggest that in <term id="T43" lex="human_T_lymphocyte" sem="Cell_natural">human T lymphocytes</term> both <term id="T44" lex="Dex" sem="Lipid">Dex</term> and <term id="T45" lex="CsA" sem="Organic_compound_other">CsA</term> inhibited <term id="T46" lex="IL-2_gene_transcription" sem="Other"><term id="T47" lex="IL-2_gene" sem="DNA_domain_or_region">IL-2 gene</term> transcription</term> through interference with <term id="T48" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> <term id="T49" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T50" lex="NF-AT" sem="Protein_molecule">NF-AT</term>.</sentence>
<event CL="L2" KT="Analysis" id="E39" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T49"/>
<cause idref="T44"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <clueType>through interference</clueType> <linkTheme>with</linkTheme> transcription factors AP-1 and NF-AT.</clue>
</event>
<event CL="L2" KT="Analysis" id="E40" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T50"/>
<cause idref="T44"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <clueType>through interference</clueType> <linkTheme>with</linkTheme> transcription factors AP-1 and NF-AT.</clue>
</event>
<event CL="L2" KT="Analysis" id="E41" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T49"/>
<cause idref="T45"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <clueType>through interference</clueType> <linkTheme>with</linkTheme> transcription factors AP-1 and NF-AT.</clue>
</event>
<event CL="L2" KT="Analysis" id="E42" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T50"/>
<cause idref="T45"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <clueType>through interference</clueType> <linkTheme>with</linkTheme> transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E43">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>These results suggest that in human T lymphocytes both Dex and CsA inhibited IL-2 gene <clueType>transcription</clueType> through interference with transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E44" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="E39"/>
<clue>These results suggest that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <linkCause>through</linkCause> interference with transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E45" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="E40"/>
<clue>These results suggest that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <linkCause>through</linkCause> interference with transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E46" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="E41"/>
<clue>These results suggest that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <linkCause>through</linkCause> interference with transcription factors AP-1 and NF-AT.</clue>
</event>
<event KT="Other" id="E47" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="E42"/>
<clue>These results suggest that in human T lymphocytes both Dex and CsA <clueType>inhibited</clueType> IL-2 gene transcription <linkCause>through</linkCause> interference with transcription factors AP-1 and NF-AT.</clue>
</event>
<sentence id="S11">We propose that, while maximum inhibition may involve interaction with both <term id="T51" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term>, <term id="T52" lex="AP-1" sem="Protein_molecule">AP-1</term> is the primary target of <term id="T53" lex="Dex" sem="Lipid">Dex</term>.</sentence>
<event KT="Other" Manner="High" id="E48">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<clue>We propose that, while <clueManner>maximum</clueManner> <clueType>inhibition</clueType> may involve interaction with both transcription factors, AP-1 is the primary target of Dex.</clue>
<comment>NO COREFTEHEME</comment></event>
<event KT="Other" id="E49">
<type class="Binding"/>
<theme idref="T49"/>
<theme idref="T53"/>
<clue>We propose that, while maximum inhibition may involve <clueType>interaction</clueType> <linkTheme>with</linkTheme> <corefTheme>both transcription factors</corefTheme>, AP-1 is the primary target of Dex.</clue>
<comment>NO COREFTHEME FOR T53</comment></event>
<event KT="Other" id="E50">
<type class="Binding"/>
<theme idref="T50"/>
<theme idref="T53"/>
<clue>We propose that, while maximum inhibition may involve <clueType>interaction</clueType> <linkTheme>with</linkTheme> <corefTheme>both transcription factors</corefTheme>, AP-1 is the primary target of Dex.</clue>
<comment>NO COREFTHEME FOR T53</comment></event>
<event CL="L1" KT="Analysis" id="E51">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="E49"/>
<cause idref="E50"/>
<clue>We propose that, while maximum inhibition <clueKT><clueCL>may</clueCL></clueKT> <clueType>involve</clueType> interaction with both transcription factors, AP-1 is the primary target of Dex.</clue>
</event>
<event CL="L2" KT="Analysis" id="E52">
<type class="Regulation"/>
<theme idref="T52"/>
<cause idref="T53"/>
<clue>We <clueKT><clueCL>propose</clueCL></clueKT> that, while maximum inhibition may involve interaction with both transcription factors, AP-1 <clueType>is the primary target</clueType> <linkCause>of</linkCause> Dex.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
